Correspondence 0001193125-23-231671 from BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: Sept. 8, 2023 · CIK: 0000811240 · Accession: 0001193125-23-231671
AI Filing Summary & Sentiment
File numbers found in text: 333-273372
Show Raw Text
CORRESP 1 filename1.htm CORRESP September 8, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Biolase, Inc. Registration Statement on Form S-1, as amended File 333-273372 Withdrawal of Request for Acceleration of Effective Date Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on September 6, 2023, in which we requested acceleration of the above-referenced Registration Statement. We are no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request for acceleration of the effective date. [Signature Page to Follow] Very truly yours, LAKE STREET CAPITAL MARKETS, LLC As Representative of the Several Underwriters Named in the Underwriting Agreement By: /s/ Michael Townley Name: Michael Townley Title: Head of Investment Banking MAXIM GROUP LLC As Representative of the Several Underwriters Named in the Underwriting Agreement By: /s/ Clifford A. Teller Name: Clifford A. Teller Title: Executive Managing Director, Investment Banking [Signature Page to Underwriters’ Acceleration Request Withdrawal]